Abtri Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 01-07-2024
- Paid Up Capital ₹ 0.10 M
as on 01-07-2024
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Net Worth -25.73%
(FY 2022)
- Total Assets 14.27%
(FY 2022)
About Abtri Biotech
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Chandrasekaran Sathyavani and Krishnaraj Mannangatti serve as directors at the Company.
- CIN/LLPIN
U74999TN2016PTC111562
- Company No.
111562
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jul 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Abtri Biotech Private Limited offer?
Abtri Biotech Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Water Treatment Chemicals.
Who are the key members and board of directors at Abtri Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishnaraj Mannangatti  | Director | 20-Jul-2016 | Current |
| Chandrasekaran Sathyavani | Director | 20-Jul-2016 | Current |
Financial Performance of Abtri Biotech.
Abtri Biotech Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 25.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Abtri Biotech?
In 2019, Abtri Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jayagen Biologics Private LimitedActive 5 years 1 monthChandrasekaran Sathyavani and Krishnaraj Mannangatti are mutual person
Cybrids Agro Biotech Private LimitedActive 5 years 1 monthChandrasekaran Sathyavani and Krishnaraj Mannangatti are mutual person
Chetti Masala Food And Spices Private LimitedActive 6 years 2 monthsChandrasekaran Sathyavani and Krishnaraj Mannangatti are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Abtri Biotech?
Unlock and access historical data on people associated with Abtri Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abtri Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abtri Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
